Boston Scientific (NYSE:BSX) doubled its earnings per share during the 4th quarter on an 80% profit surge eked out despite flat sales growth that still topped analysts’ expectations.
Q4
Align Technology beats The Street with tripled Q4 profits
California’s Align Technology (NSDQ:ALGN) posted some very strong numbers for its 4th quarter, boosting full-year figures beyond Wall Street’s expectations.
Legal win, buyouts boost Bard’s bottom line
A nearly $900 million award from W.L. Gore boosted C.R. Bard’s bottom line in Q4 as sales inch up 3% in 2013: Officials announce $500 million share buyback plan.
Cardiovascular Systems surges on Q2 results, outlook
Cardiovascular Systems (NSDQ:CSII) shares surged nearly 20% today on better-than-expected fiscal 2nd-quarter numbers and a 3rd-quarter outlook that came out well ahead of Wall Street’s forecast.
Zimmer’s Q4 profits surge
Philips Healthcare’s Q4, 2013 profits rise despite lower sales
Philips Healthcare (NYSE:PHG) saw its profits rise at significant double-digit clip during the 4th quarter and 2013, despite declining sales.
Intuitive Surgical loses points after-hours after posting 2013 earnings
Sunnyvale, Calif.-based surgical robotics maker Intuitive Surgical (NSDQ:ISRG) lost a little Wall Street love today after the company reported 4th quarter and fiscal 2013 financial figures.
Baxter beats The Street with Q4 numbers, but Gambro buy pushes profits down
Hill-Rom lays of 350 to save $30M amid rough outlook
Hill-Rom Holdings (NYSE:HRC) announced today that it will cut about 350 employees in efforts to save about $30 million annually as the device maker looks forward to a potentially tough year.